Korean Circ J.  2020 Apr;50(4):328-329. 10.4070/kcj.2020.0040.

Can Genoss DESâ„¢ Stand Out in the Crowd of Stents?

• Lee JH
• Park JH

• KMID: 2471282
• DOI: http://doi.org/10.4070/kcj.2020.0040

Abstract

No abstract available.

MeSH Terms

Stents*

Reference

1. Holmes DR Jr, Kereiakes DJ, Laskey WK, et al. Thrombosis and drug-eluting stents: an objective appraisal. J Am Coll Cardiol. 2007; 50:109–118.

2. El-Hayek G, Bangalore S, Casso Dominguez A, et al. Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents. JACC Cardiovasc Interv. 2017; 10:462–473.

3. Yang HM, Seo KW, Yoon J, et al. Clinical and angiographic outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal bioresorbable polymer. Korean Circ J. 2017; 47:898–906.

4. Youn YJ, Yoo SY, Lee JW, et al. Safety and efficacy of a new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer in real-world practice. Korean Circ J. 2020; 50:317–327.